New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 25, 2019 - The FDA approved Samsung Bioepis’ Eticovo (etanercept-ykro), a biosimilar to Amgen’s Enbrel® (etanercept).
Download PDF
Return to publications
